瑞丰光电 reported revenue of ¥1.07B for the period ended 2026-06-30, +27.5% year on year. Net income was ¥0.06B, a 5.4% net margin on a 19.5% gross margin. The largest revenue line is LED产品 at 91% of the total. Free cash flow for the period was ¥0.02B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.07B | +27.5% |
| Gross profit | ¥0.21B | — |
| Operating income | ¥0.06B | — |
| Net income | ¥0.06B | +68.6% |
| Gross margin | 19.5% | Net margin 5.4% |
| Revenue Q/Q | +25.5% | — |
| Segment | Revenue | Share |
|---|---|---|
| LED产品 | ¥0.98B | 91.0% |
| 电子纸产品 | ¥0.07B | 6.9% |
| 其他(补充) | ¥0.02B | 2.1% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.86B | 80.5% |
| R&D | ¥0.05B | 4.3% |
| SG&A | ¥0.10B | 9.2% |
| Tax & other | ¥0.00B | 0.2% |
| Item | Amount |
|---|---|
| Total assets | ¥4.00B |
| Total liabilities | ¥1.63B |
| Shareholders' equity | ¥2.37B |
| Equity / assets | 59.2% |
| Operating cash flow | ¥0.06B |
| Capital expenditure | ¥0.03B |
| Free cash flow | ¥0.02B |
| Cash conversion (OCF / net income) | 24% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
佳云科技 ・ 瑞丰高材 ・ 迪安诊断 ・ ST天玑 ・ 宝莱特 ・ 融捷健康 ・ 新开普 ・ 依米康 ・ 初灵信息 ・ 金信诺 ・ 卫宁健康 ・ 仟源医药
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies